Saneca Pharmaceuticals has been acquired by AZC Group
December 2025 — AZC Group has acquired controlling ownership of Saneca Pharmaceuticals AS, a Slovakia-based pharmaceutical contract development and manufacturing organization (CDMO).
Saneca Pharmaceuticals is a Slovakia-based pharmaceutical CDMO focused on the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients (APIs). The company operates across the pharmaceutical value chain, offering end-to-end services from product development to commercial-scale manufacturing. It serves a diversified base of pharmaceutical companies, primarily in Europe, and produces over 1,300 SKUs across a broad range of dosage forms.
AZC is a diversified industrial group headquartered in Slovakia, operating across multiple sectors including biofuels, chemicals, agriculture, transport and logistics. The group manages a portfolio of industrial assets across several countries and integrates upstream and downstream activities within its businesses.
Our role in the transaction
Oaklins’ team in Slovakia acted as the sole financial advisor to the seller.
Talk to the deal team
Related deals
Be-Cloud has been acquired by PSG Equity
Be-Cloud, backed by B&Capital since 2021, has been acquired by PSG Equity, a leading growth equity firm specializing in software and technology-enabled services. The transaction marks the full exit of B&Capital and the reinvestment of Be-Cloud’s founders, Lenny and Sébastien Vercruysse, alongside PSG Equity.
Learn moreMattina Holding has sold a 5% stake in Gens Aurea via accelerated bookbuild
Mattina Holding S.A. (DVC Partners) has sold a 5% stake in Italian company Gens Aurea S.p.A. through an accelerated bookbuild, raising approximately US$69.96 million.
Learn moreCibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn more